Sign In
Buy BCLI
$0.770
-0.0217 (-2.74%)
At Close: Jun 03, 2026
Abner Herrman & Brock Llc Buys Synopsys Inc, Air Products & Chemicals Inc, Pfizer Inc, ...
12:00am, Thursday, 09'th Apr 2020BCLI: $1.5M Grant from Israel Innovation Authority…
10:40am, Wednesday, 08'th Apr 2020
By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Coronavirus Epidemic Not Affecting Business Operations In March 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI
Sankesh Abbhi Reports 9.04% Stake In Brainstorm Cell Therapeutics Inc As Of March 30
10:10am, Wednesday, 08'th Apr 2020Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More
12:21pm, Friday, 03'rd Apr 2020
The coronavirus pandemic has shaken the global economy, but three life sciences venture capital firms this week announced new funds totaling nearly $3
BrainStorm Wins $1.5M Non-Dilutive Grant By Israel Innovation Authority
11:00am, Friday, 03'rd Apr 2020BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority
10:59am, Friday, 03'rd Apr 2020
NEW YORK and PETACH TIKVAH, Israel, April 03, 2020 -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for.
BrainStorm Awarded $–.5 Million Non-Dilutive Grant for —…—… by the Israel Innovation ...
12:00am, Friday, 03'rd Apr 2020Brainstorm Cell Therapeutics Names Setboun Chief Operating Officer
09:26pm, Thursday, 02'nd Apr 2020
David Setboun has been appointed executive vice president and chief operating officer of Brainstorm Cell Therapeutics (NASDAQ: ]). He is joining New
David Setboun Joins BrainStorm as Executive Vice President and Chief Operating Officer
01:00pm, Wednesday, 01'st Apr 2020
International Pharmaceutical Veteran to Lead Global Business and Commercial Development Ralph Kern, MD, MHSc, Promoted to President NEW YORK, April 01, 2020 -- BrainStorm.
BrainStorm Appoints Prof. Jacob Frenkel Chairman of the Board of Directors
02:52pm, Tuesday, 31'st Mar 2020BrainStorm Appoints Renowned Distinguished Economist, Prof. Jacob Frenkel, Chairman of the Board of Directors
08:00am, Tuesday, 31'st Mar 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cell technologies for neurodegenerative diseases, today announced the appointment of Jacob Frenkel, Ph.D., as Chairman of the B
Analyzing Denali Therapeutics (NASDAQ:DNLI) and Brainstorm Cell Therapeutics (NASDAQ:BCLI)
05:52am, Thursday, 26'th Mar 2020
Denali Therapeutics (NASDAQ:DNLI) and Brainstorm Cell Therapeutics (NASDAQ:BCLI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the s
The autologous cell therapy market size has the potential to grow by USD 1.97 billion during 2020-2024.
Brainstorm Therapeutics Shares Pare All Recent Gains Since Trader Circulation Of Co. Tweet; Shares Still Up 8% for Session
12:00am, Tuesday, 24'th Mar 2020
Global Autologous Cell Therapy Market 2020-2024 The analyst has been monitoring the global autologous cell therapy market 2020-2024 and it is poised to grow by USD 1.97 bn during 2020-2024, progressin
